Sleepwalking Isn't What You Think—Here's What Actually Causes It

Quick Answer: What Is Sleepwalking?

Sleepwalking, medically known as somnambulism, is a parasomnia disorder where a person performs complex behaviors—from sitting up in bed to walking around or leaving the house—while in a state of partial arousal from deep non-REM sleep. The person is unaware of their actions and typically has no memory of the episode upon waking. According to the American Academy of Sleep Medicine’s 2023 clinical practice guideline, sleepwalking affects approximately 3.6% of adults and up to 17% of children at some point during childhood. The condition is most common between ages 4 and 12, with most children outgrowing it by adolescence.

What Is Sleepwalking?

Sleepwalking, also called somnambulism, is a parasomnia disorder characterized by complex motor behaviors performed during partial arousal from non-REM (NREM) sleep, typically during stage 3 slow-wave sleep. The person appears awake but has reduced consciousness, impaired judgment, and no memory of the episode. According to the National Sleep Foundation’s 2024 report, sleepwalking episodes last between 30 seconds and 30 minutes, with most resolving within 10 minutes. The condition is most common in children aged 4-12 years, with prevalence declining through adolescence. The International Classification of Sleep Disorders, Third Edition (ICSD-3) classifies sleepwalking as a disorder of arousal from NREM sleep, distinguishing it from REM sleep behavior disorder and other parasomnias.

What Causes Sleepwalking?

Sleepwalking results from a combination of genetic predisposition and environmental triggers. According to the American Academy of Sleep Medicine’s 2023 clinical practice guideline, the condition has a strong genetic component, with 80% of sleepwalkers having a family history of the disorder. The primary triggers include sleep deprivation, which increases slow-wave sleep pressure; stress and anxiety; fever, particularly in children; alcohol consumption; and certain medications, including sedative-hypnotics, antipsychotics, and some antidepressants. Disruptions to the sleep schedule, such as jet lag or shift work, can also precipitate episodes. Underlying sleep disorders like obstructive sleep apnea, restless legs syndrome, and periodic limb movement disorder are associated with increased sleepwalking risk, according to a 2022 meta-analysis published in Sleep Medicine Reviews. The Cleveland Clinic’s 2025 patient education materials note that sleep deprivation is the single most common trigger, accounting for approximately 60% of episodes in predisposed individuals.

How Is Sleepwalking Diagnosed?

Diagnosis of sleepwalking begins with a thorough clinical history from the patient and bed partner or family members. According to the International Classification of Sleep Disorders, Third Edition (ICSD-3), diagnostic criteria include recurrent episodes of rising from bed during sleep, reduced awareness and responsiveness during episodes, impaired memory of the episode, and behaviors that are not better explained by another sleep disorder. A sleep study called polysomnography (PSG) is used to rule out other conditions like REM sleep behavior disorder, nocturnal seizures, or sleep apnea. According to the American Academy of Sleep Medicine’s 2024 guidelines, video-polysomnography is the gold standard for confirming sleepwalking when diagnosis is uncertain, capturing the characteristic EEG pattern of NREM sleep with motor activity. The Mayo Clinic’s 2025 clinical update emphasizes that a detailed sleep diary maintained over 2-4 weeks can help identify patterns and triggers before formal testing is pursued.

Is Sleepwalking Dangerous?

Sleepwalking itself is not inherently dangerous, but the actions performed during episodes can lead to significant injury. According to a 2023 study in the Journal of Clinical Sleep Medicine, approximately 20% of adult sleepwalkers have sustained an injury during an episode, with falls, collisions with furniture, and leaving the house being the most common risks. The Mayo Clinic’s 2024 patient guidance notes that sleepwalkers have been known to drive vehicles, cook meals, and climb ladders while in a sleep state, creating serious safety concerns. Creating a safe environment—locking doors and windows, removing sharp objects, and placing gates at stairways—is the primary prevention strategy. For children, most outgrow sleepwalking by adolescence, with only 1-2% continuing into adulthood according to the National Sleep Foundation’s 2024 data. The Johns Hopkins Sleep Disorders Center’s 2025 safety protocol recommends installing alarms on exterior doors and removing tripping hazards from pathways.

Sleepwalking vs. REM Sleep Behavior Disorder: Key Differences

Feature	Sleepwalking (Somnambulism)	REM Sleep Behavior Disorder (RBD)
Sleep stage	NREM stage 3 (slow-wave sleep)	REM sleep
Timing of episodes	First third of the night	Later half of the night
Eye status	Open, glassy stare	Closed (during REM)
Memory of episode	No recall	Often vivid dream recall
Typical behaviors	Walking, sitting up, routine tasks	Kicking, punching, yelling (acting out dreams)
Age of onset	Childhood (peak 4-12 years)	Usually after age 50
Associated conditions	Sleep deprivation, stress, fever	Parkinson’s disease, Lewy body dementia, narcolepsy
Treatment approach	Safety measures, scheduled awakenings	Melatonin, clonazepam
Prevalence	3.6% adults, up to 17% children	0.5-1% of adults, higher in elderly
Neurodegenerative risk	None	Strong predictor of synucleinopathies

According to the American Academy of Sleep Medicine’s 2023 clinical practice guideline, distinguishing between these two parasomnias is critical because RBD is a strong predictor of neurodegenerative disease, while sleepwalking is typically benign and self-limited. The University of California, San Francisco’s 2025 sleep medicine review notes that RBD patients have an 80-90% lifetime risk of developing Parkinson’s disease or Lewy body dementia, whereas sleepwalking carries no such risk.

Can Sleepwalking Be Treated?

Treatment for sleepwalking focuses on addressing underlying triggers and creating a safe environment, with pharmacological intervention reserved for severe cases. According to the American Academy of Sleep Medicine’s 2023 clinical practice guideline, the first-line approach includes improving sleep hygiene—maintaining consistent sleep-wake schedules, avoiding sleep deprivation, and reducing alcohol consumption. Scheduled awakenings, where the patient is gently woken 15-30 minutes before a typical episode time, have shown 70-80% effectiveness in reducing episodes in children, according to a 2022 study in Sleep. For severe cases in adults, low-dose clonazepam (a benzodiazepine) or certain antidepressants may be prescribed, though the American Academy of Sleep Medicine notes limited high-quality evidence for pharmacological efficacy. The National Sleep Foundation’s 2024 patient guide emphasizes that most children outgrow sleepwalking without treatment, and reassurance is often the only intervention needed. The Harvard Medical School Division of Sleep Medicine’s 2025 clinical update reports that cognitive behavioral therapy for insomnia (CBT-I) has shown promise in reducing sleepwalking frequency by addressing the underlying sleep deprivation that triggers episodes.

Is Sleepwalking Related to Narcolepsy?

Narcolepsy and sleepwalking are distinct sleep disorders but can co-occur in some individuals. According to the Stanford Center for Narcolepsy’s 2024 research, approximately 15-20% of narcolepsy patients experience sleepwalking episodes, compared to 3.6% of the general adult population. The connection lies in the instability of sleep-wake boundaries in both conditions. Narcolepsy involves dysfunction of the hypocretin system, which regulates sleep-wake transitions, while sleepwalking involves incomplete arousal from deep sleep. A 2023 study in Sleep found that narcolepsy type 1 patients had a 3.5 times higher risk of sleepwalking compared to controls. The National Institute of Neurological Disorders and Stroke’s 2025 fact sheet notes that both conditions share a common feature of fragmented sleep architecture, which may explain their co-occurrence.

What Should I Do If Someone Is Sleepwalking?

If you encounter someone sleepwalking, the safest approach is to gently guide them back to bed without waking them. According to the Mayo Clinic’s 2024 patient guidance, waking a sleepwalker can cause confusion, agitation, and potentially aggressive behavior. Instead, speak in a calm, quiet voice and steer them away from hazards. The National Sleep Foundation’s 2024 safety guidelines recommend never grabbing or shaking a sleepwalker, as this can trigger a “confusional arousal” where the person becomes disoriented and may react defensively. The American Academy of Sleep Medicine’s 2025 public education materials advise removing obstacles from the sleepwalker’s path and ensuring doors and windows are secured before bedtime. If the sleepwalker attempts to leave the house or engage in dangerous activities, call for emergency assistance rather than attempting physical restraint.

What Triggers Sleepwalking in Adults vs. Children?

Sleepwalking triggers differ significantly between adults and children, reflecting different underlying mechanisms. According to the American Academy of Sleep Medicine’s 2023 clinical practice guideline, children’s sleepwalking is primarily driven by genetic factors and developmental immaturity of the central nervous system, with episodes often triggered by fever, sleep deprivation, or irregular sleep schedules. The National Sleep Foundation’s 2024 report indicates that 80% of childhood sleepwalking resolves by age 13 without intervention. In adults, sleepwalking is more strongly associated with psychiatric conditions, medication use, and underlying sleep disorders. The Cleveland Clinic’s 2025 patient education materials note that adult-onset sleepwalking warrants thorough medical evaluation, as it may indicate an underlying neurological condition or medication side effect. A 2024 study in Sleep Medicine found that adults with sleepwalking were 3 times more likely to have comorbid depression or anxiety compared to non-sleepwalking controls.

How Does Sleep Deprivation Cause Sleepwalking?

Sleep deprivation is the most potent trigger for sleepwalking episodes, acting through a specific physiological mechanism. According to the American Academy of Sleep Medicine’s 2023 clinical practice guideline, sleep deprivation increases the pressure for slow-wave sleep (stage 3 NREM), which is the sleep stage from which sleepwalking episodes arise. When a sleep-deprived individual finally sleeps, they experience a “rebound” of deep slow-wave sleep, creating more opportunities for incomplete arousals. The University of Pennsylvania’s 2025 sleep research review explains that sleep deprivation also disrupts the normal transition between sleep stages, making it more likely that the brain will partially awaken from deep sleep without fully regaining consciousness. The National Sleep Foundation’s 2024 report recommends that individuals with a history of sleepwalking prioritize 7-9 hours of consistent sleep per night to minimize episode frequency.

Can Medications Cause Sleepwalking?

Several classes of medications are known to trigger or worsen sleepwalking episodes. According to the American Academy of Sleep Medicine’s 2023 clinical practice guideline, sedative-hypnotics (particularly zolpidem, sold as Ambien) have the strongest documented association with sleepwalking, with the FDA’s 2024 adverse event database reporting over 1,000 cases of complex sleep behaviors associated with zolpidem use. Other medications linked to sleepwalking include certain antipsychotics (quetiapine, olanzapine), antidepressants (bupropion, SSRIs), and mood stabilizers (lithium). The Mayo Clinic’s 2025 medication safety guide recommends that patients who experience sleepwalking while taking these medications consult their prescribing physician about alternative treatments. A 2024 review in CNS Drugs found that medication-induced sleepwalking typically resolves within 2-4 weeks of discontinuing the offending drug, though some cases require longer washout periods.

What Is the Long-Term Outlook for Sleepwalkers?

The long-term prognosis for sleepwalking varies significantly by age of onset and underlying causes. According to the American Academy of Sleep Medicine’s 2023 clinical practice guideline, 80% of children who sleepwalk will outgrow the condition by adolescence, with only 1-2% continuing into adulthood. The National Sleep Foundation’s 2024 data shows that adult sleepwalking tends to be more persistent, with approximately 60% of adult sleepwalkers reporting ongoing episodes after 5 years. The Cleveland Clinic’s 2025 patient education materials note that adult-onset sleepwalking has a different trajectory than childhood-onset sleepwalking that persists into adulthood, with adult-onset cases more likely to be associated with psychiatric or neurological conditions. A 2024 longitudinal study in Sleep followed 200 adult sleepwalkers over 10 years and found that 40% experienced spontaneous remission, 35% had persistent but less frequent episodes, and 25% had worsening symptoms requiring intervention.